PTCE flashcards
PTCE · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Levothyroxine administration
- Synthetic T4 used for hypothyroidism; it is taken on an empty stomach 30 to 60 minutes before breakfast and separated from calcium, iron, and antacids by at least four hours.
- Metformin lactic acidosis risk
- Biguanide antidiabetic with a boxed warning for lactic acidosis; hold before iodinated contrast procedures when eGFR is 30 to 60 mL/min/1.73 m2 and during acute illness.
- Warfarin monitoring and reversal
- Vitamin K antagonist anticoagulant monitored with the INR; phytonadione (vitamin K) reverses its effect, and many drugs plus vitamin K-rich foods alter the INR.
- Vancomycin adverse effects
- Glycopeptide antibiotic that is nephrotoxic and ototoxic; infusing too rapidly causes histamine-mediated flushing called red man syndrome, and trough levels guide dosing for serious infections.
- Insulin storage requirements
- Unopened insulin vials and pens are refrigerated at 2 to 8 degrees Celsius and never frozen; in-use pens stay at room temperature and are discarded per the manufacturer's labeled number of days.
- Methotrexate weekly dosing hazard
- For rheumatoid arthritis and psoriasis, methotrexate is given once weekly; daily dosing causes fatal bone marrow suppression, and folic acid or leucovorin reduces toxicity.
- ACE inhibitor adverse effects
- Cough, hyperkalemia, and angioedema are characteristic of angiotensin-converting enzyme inhibitors, which are contraindicated during pregnancy and require monitoring of potassium and renal function.
- Therapeutic equivalence AB rating
- In the FDA Orange Book, an AB rating means two products are therapeutically equivalent and may be substituted because they are pharmaceutically equivalent and bioequivalent.
- Amiodarone monitoring parameters
- Class III antiarrhythmic that accumulates in tissue and can cause thyroid dysfunction, pulmonary fibrosis, corneal microdeposits, and hepatotoxicity, so baseline and periodic thyroid, liver, and pulmonary monitoring is required.
- Schedule II refill rule
- Schedule II prescriptions cannot be refilled; a prescriber must issue a new prescription for each fill, and partial fills are permitted only under specific exceptions such as long-term care.
- Schedule III-V refill limits
- These prescriptions may be refilled up to five times within six months of the date the prescription was issued; after five refills or six months, a new prescription is required.
- DEA Form 222
- The order form required to purchase Schedule I and II controlled substances; it must be completed accurately, and electronic ordering through CSOS is now permitted.
- DEA Form 106
- Used to report the theft or significant loss of controlled substances to the DEA field division; the pharmacy must also notify local authorities as required.
- Pseudoephedrine sales limits
- Under the Combat Methamphetamine Epidemic Act, a purchaser may buy no more than 3.6 grams of ephedrine or pseudoephedrine per day and 9 grams in any 30-day period.
- Poison Prevention Packaging Act
- Requires child-resistant packaging for most oral prescription drugs unless the prescriber specifies otherwise or the patient requests non-child-resistant containers in writing or verbally.
- DSCSA product identifier
- A unique code on each package containing the NDC, serial number, lot number, and expiration date; pharmacies must verify suspect products and keep transaction records for six years.
- Biennial controlled substance inventory
- Federal law requires an inventory every two years; Schedule II counts must be exact, while Schedule III through V may be estimated unless a container holds 1000 or more units.
- Do not use abbreviations
- ISMP and The Joint Commission prohibit U for units, QD and QOD, MS for morphine sulfate, naked decimals such as .5 mg, and trailing zeros such as 5.0 mg.
- Tall man lettering
- Mixed-case capitalization highlights differing letters in look-alike drug names, such as hydrOXYzine versus hydrALAZINE and glipiZIDE versus glyBURIDE, reducing selection errors.
- USP 797 buffer area
- The room where sterile compounding occurs must meet ISO Class 7 at rest and in operation and must house an ISO Class 5 primary engineering control such as a laminar airflow workbench.
- USP 800 hazardous drug handling
- Requires containment strategies for hazardous drugs, including closed-system transfer devices, two pairs of chemotherapy gloves, gowns, and a NIOSH-certified respirator when handling spills.
- Refrigerator temperature range
- Pharmaceutical refrigerators are maintained at 2 to 8 degrees Celsius (36 to 46 Fahrenheit) with continuous monitoring and documented readings; freezing damages most vaccines and insulin.
- High-alert medication double check
- Drugs with a heightened risk of harm, such as insulin, heparin, opioids, and concentrated electrolytes, require independent double checks and separate storage to prevent catastrophic errors.
- Hazardous drug spill kit
- Contains absorbent pads, chemotherapy gloves, gowns, shoe covers, eye protection, and waste bags; spills are cleaned from the outside inward and disposed of as trace hazardous waste.
- Sentinel event root cause analysis
- An unexpected occurrence involving death or serious harm triggers a root cause analysis, which The Joint Commission expects to be completed within 45 calendar days of the event.
- Days supply formula
- Divide the total quantity dispensed by the quantity used per day; for example, 90 tablets taken three times daily equals a 30-day supply.
- C1V1 dilution equation
- The concentration of a stock solution multiplied by its volume equals the final concentration multiplied by the final volume, allowing calculation of diluent needed to reach a target strength.
- Percent weight-volume strength
- Percent weight-volume expresses grams of solute per 100 mL of solution; a 1:1000 ratio strength equals 0.1 percent weight-volume or 1 mg per mL.
- Cockcroft-Gault creatinine clearance
- Estimated creatinine clearance equals (140 minus age) times weight in kilograms, divided by 72 times serum creatinine, and multiplied by 0.85 for female patients.
- DEA number verification
- Add the first, third, and fifth digits to twice the sum of the second, fourth, and sixth digits; the last digit of that total matches the final DEA number digit.
- IV drip rate formula
- Drops per minute equal the volume in milliliters multiplied by the drop factor in drops per milliliter, divided by the infusion time in minutes.
- Mosteller body surface area
- Body surface area in square meters equals the square root of height in centimeters times weight in kilograms divided by 3600.